Identiv, Inc. — Director's Dealing 2020

Feb 8, 2020

SEC Form 4/A — Form 4/A

Issuer: Identiv, Inc. (INVE)
CIK: 0001036044
Period of Report: 2020-02-03

Reporting Person: Bleichroeder LP (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-03	Common Stock	P	36889	$4.99	Acquired	1924893	Indirect
2020-02-03	Common Stock	P	110000	$4.87	Acquired	2034893	Indirect
2020-02-04	Common Stock	P	13111	$4.99	Acquired	2048004	Indirect
2020-02-04	Common Stock	P	8222	$4.83	Acquired	2056226	Indirect
2020-02-05	Common Stock	P	10113	$4.9	Acquired	2066339	Indirect

Footnotes

F1: The reported price in Column 4 is a weighted average price. These shares were bought in multiple transactions. Prices ranged from $4.95 to $5.00 per share, inclusive. The
Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F2: Total amount of securities reported in item 5 does not include previously reported 5,000,000 of Series B Convertible Preferred shares.

F3: The shares of Common Stock reported herein are indirectly beneficially owned by Bleichroeder, LP (Bleichroeder), a Delaware limited partnership, an investment adviser registered under the Investment Advisers Act of 1940. Bleichroeder is the registered investment adviser to Biotechnology Master Fund, Ltd. as well as to 21 April Fund, LP and 21 April Fund, Ltd. (collectively, the "Funds"). The shares of Common Stock reported herein are directly held by the Funds and other managed accounts. Bleichroeder disclaims beneficial ownership of the shares of Common Stock held directly by the Funds and other managed accounts except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder is the beneficial owner of any such securities.

F4: The reported price in Column 4 is a weighted average price. These shares were bought in multiple transactions. Prices ranged from $4.795 to $5.10 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F5: The reported price in Column 4 is a weighted average price. These shares were bought in multiple transactions. Prices ranged from $4.90 to $5.05 per share, inclusive. The
Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F6: The reported price in Column 4 is a weighted average price. These shares were bought in multiple transactions. Prices ranged from $4.805 to $4.88 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F7: The reported price in Column 4 is a weighted average price. These shares were bought in multiple transactions. Prices ranged from $4.825 to $4.95 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.